Member of Farmavita.Net is looking for license for use of EU CTD Dossier for Lansoprasole disintegrating tablets of 15mg - 30 mg, with supply of bulk blisters. License-in territory is Poland.
Products suitable for MA transfer or MRP will have priority.
Forecast of demand is:
0,03 g x14 tabs.
0,015 g x28 tabs.
Offer is valid subject to confirmation of patent non infringement status of product. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Farmavita.Net is not owner of offered products/licenses and do not take any liability related to them. However, as the licensing agent we do our best to facilitate that closed licensing agreements are made on mutual benefit of contracting parties and without infringement of intellectual property of third parties.
|Pharma licensing||In-licensing (demand)|